Medi Assist Healthcare Services544088Share buyback news

Board approves buyback of up to ~11.59 lakh shares at ₹ 425/- per share via tender offer

Board approved buyback of up to ~11.59 lakh equity shares at ₹ 425/- per share, total up to ~₹ 49.27 crore.

By ScoutQuest · Tue 3 Nov 2026, 5:39 PM IST · 3 min read

Buyback size: up to ~11.59 lakh equity shares
Buyback price: ₹ 425/- per share
Total buyback amount: up to ~₹ 49.27 crore

What the board approved

The Board met on October 30, 2026 and approved a buyback of up to ~11.59 lakh fully paid-up equity shares at ₹ 425/- per share, payable in cash. The aggregate amount works out to not more than ~₹ 49.27 crore. The shares will be bought through the tender offer route, on a proportionate basis, from shareholders holding shares on the record date of November 20, 2026.

Size in context

The ~11.59 lakh shares represent 1.55% of the company's total paid-up equity share capital.
The buyback size equals 10% of the aggregate of paid-up equity share capital and free reserves on a standalone basis, and 5.97% on a consolidated basis, as per the audited financial statements for the year ended March 31, 2026.

Price and premium

The resolution states that the ₹ 425/- buyback price carries a premium of 50.63% over the closing price of the shares on both NSE and BSE as on October 26, 2026, the trading day immediately preceding the date the exchanges were intimated of the board meeting.

Who can tender

All shareholders holding shares on the record date can participate, on a proportionate basis.
The promoters and members of the promoter group have expressed their intention not to tender their shares in the buyback, and their letters of intention were taken on record by the board.
15% of the number of shares proposed to be bought back, or the number of shares entitled as per the shareholding of small shareholders, whichever is higher, is reserved for small shareholders. If shares tendered are less than this reservation, the balance is adjusted in the general category.

How it is funded

The buyback is to be implemented out of free reserves and/or the securities premium account and/or other permitted sources. The amount required is intended to be met from the company's current balances of cash and cash equivalents, proceeds of disposal of its investments and/or internal accruals, and not from borrowed funds.

Why the company says it is doing this

The board resolution describes the buyback as a capital allocation decision to return surplus funds that are over and above ordinary capital requirements, including planned spending on technology, international growth and strategic acquisitions. The company expects it to improve earnings per share and return on equity. Shareholders who choose not to tender would see their percentage shareholding rise after the buyback, without additional investment.

Other points shareholders should note

The board or buyback committee may, until one working day before the record date, increase the buyback price and reduce the number of shares bought back, as long as the buyback size stays unchanged.
The company will not issue fresh shares or other securities during the buyback period, except in discharge of subsisting obligations such as employee stock option schemes.
The shares bought back will be extinguished, and the buyback will not result in delisting of the shares.
The buyback must be completed within the timeline fixed in the resolution, and the company has confirmed there are no subsisting defaults in repayment of its dues.

Also from Medi Assist Healthcare Services